TNDM Crosses Above Average Analyst Target
August 10, 2018 at 07:53 AM EDT
In recent trading, shares of Tandem Diabetes Care Inc (TNDM) have crossed above the average analyst 12-month target price of $30.67, changing hands for $31.44/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher level..